Get Live Data

Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Coca-Cola HBC Share Price
  4. Coca-Cola HBC Share Regulatory News
  5. Block listing Interim Review

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Coca-Cola HBC Information

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,958.00    38.00 (0.77%)
Bid:
4,952.00
Ask:
4,956.00
Spread: 4.00 (0.081%)
Market Cap: £18.07b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Block listing Interim Review

3 Nov 2025 09:30

RNS Number : 8858F
Coca-Cola HBC AG
03 November 2025
 

 

BLOCK LISTING SIX MONTHLY RETURN

 

 

Date: 3 November 2025

 

Name of applicant:

Coca-Cola HBC AG

Name of scheme:

Coca-Cola HBC's Stock Options and Performance Share Award Plan

Period of return:

From:

1 May 2025

To:

31 October 2025

Balance of unallotted securities under scheme(s) from previous return:

23,658,623

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

N/A

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

N/A

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

23,658,623

 

Name of contact:

Jan Gustavsson - Company Secretary, General Counsel & Chief Corporate Development Officer

Telephone number of contact:

+41 41 726 0110

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRFIFETLELVIIE
5678910111213
Date   Source Headline
22nd Feb 20233:43 pmRNSDirector/PDMR Shareholding
20th Feb 20232:46 pmRNSDirector/PDMR Shareholding
20th Feb 20232:13 pmRNSDirector/PDMR Shareholding
16th Feb 202311:28 amRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSStrong execution drives another year of growth
1st Feb 20231:50 pmRNSIssue of equity and total voting rights
18th Jan 20232:47 pmRNSDirector/PDMR Shareholding
17th Jan 20239:34 amRNSNotice of Results
5th Jan 202310:14 amRNSAthens Exchange trading date of ordinary shares
4th Jan 20233:02 pmRNSDirector/PDMR Shareholding
20th Dec 202210:16 amRNSPost 2022 AGM Shareholder Engagement
19th Dec 20223:03 pmRNSDirector/PDMR Shareholding
1st Dec 20227:44 amRNSIssue of equity and total voting rights
18th Nov 20223:13 pmRNSDirector/PDMR Shareholding
17th Nov 20228:41 amRNSDirector/PDMR Shareholding
16th Nov 20225:06 pmRNSDirector/PDMR Shareholding
14th Nov 20222:36 pmRNSDirector/PDMR Shareholding
11th Nov 20221:32 pmRNSDirector/PDMR Shareholding
11th Nov 20221:24 pmRNSDirector/PDMR Shareholding
8th Nov 20227:00 amRNSContinued positive momentum
1st Nov 20222:50 pmRNSBlock listing Interim Review
18th Oct 20223:05 pmRNSDirector/PDMR Shareholding
13th Oct 202210:40 amRNSNotice of Results
3rd Oct 202210:03 amRNSIssue of equity and total voting rights
28th Sep 20221:28 pmRNSDirector/PDMR Shareholding
21st Sep 20225:07 pmRNSIssue of Debt
20th Sep 202211:51 amRNSDirector/PDMR Shareholding
16th Sep 202212:32 pmRNS2022 Performance Share Plan Awards
15th Sep 20225:21 pmRNSIssue of Debt
15th Sep 20222:44 pmRNSHolding(s) in Company
15th Sep 20228:49 amRNSIssue of Debt
13th Sep 202212:38 pmRNSDirector/PDMR Shareholding
7th Sep 202212:05 pmRNSHolding(s) in Company
6th Sep 20222:03 pmRNSPublication of a Prospectus
30th Aug 20229:14 amRNSHolding(s) in Company
25th Aug 20229:01 amRNSHolding(s) in Company
23rd Aug 20221:45 pmRNSHolding(s) in Company
23rd Aug 202211:06 amRNSHolding(s) in Company
18th Aug 20223:43 pmRNSHolding(s) in Company
18th Aug 202212:05 pmRNSHolding(s) in Company
18th Aug 202211:24 amRNSDirector/PDMR Shareholding
11th Aug 202212:40 pmRNSHolding(s) in Company
11th Aug 20227:00 amRNSStrong volumes, revenue, EBIT; investing in growth
9th Aug 20221:45 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSCCH agrees to acquire Three Cents
19th Jul 202212:53 pmRNSDirector/PDMR Shareholding
19th Jul 202210:48 amRNSNotice of Results
22nd Jun 202210:45 amRNSHolding(s) in Company
21st Jun 20224:28 pmRNSResult of AGM
20th Jun 20222:38 pmRNSDirector/PDMR Shareholding
5678910111213

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
IBT
Int.biotech.
LSE
-0.91%
STVG
Stvg
LSE
-6.10%
APR
APR.L
LSE
0.00%
TRX
Tissue Regenix Group
LSE
0.00%
BMPI
BMPI.L
LSE
0.00%
Trending
PLSR
Pulsar Helium
LSE
3.77%
RR.
Rolls-Royce
LSE
1.14%
ZEN
Zenith Energy
LSE
0.00%
SYME
Supply@me Cap
LSE
0.00%
MKA
Mkango Resources
LSE
3.61%